ArticleCEN case reports2024

Effects of switching from agalsidase-α to agalsidase-β on biomarkers, renal and cardiac parameters, and disease severity in fabry disease forming neutralizing antidrug antibodies: a case report.

Hisato Shima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.